Monthly Archives - December 2020

Iron ore price rises over 3%: ASX poised to open higher

03 Dec 2020 - The ASX looks set to open slightly higher this morning despite Wall Street closing relatively flat. The Pfizer-BioNTech coronavirus vaccine is set to be rolled out in the UK from early next week. Only the UK stock market reacted to the news. The Australian dollar continues to rise and iron ore shot up over 3%. Travel company Serko (ASX:SKO) report that transaction volumes have increased.

Read more...

Economy expands 3.3% in September quarter: ASX tracking 0.3% lower at noon

02 Dec 2020 - The ASX had a promising open then took a tumble before midday trade and is now tracking 0.3% lower at noon. Shares in Mesoblast (ASX:MSB) soared today after they announced the FDA has a fast track designation for remestemcel-L in the treatment of Covid-19 infection symptons. Materials is the only sector in the black so far today. Nickel Mines (ASX:NIC) has launched a $364 million capital raising to fund its initial 30% interest in the...

Read more...

Mesoblast (ASX:MSB) shares soar on FDA approval

02 Dec 2020 - Mesoblast (ASX:MSB) today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for remestemcel-L in the treatment of acute respiratory distress syndrome (ARDS) due to Covid-19 infection..

Read more...

Fresh US stimulus promise boosts markets: ASX set to open higher

2 Dec 2020 - The ASX looks set to open higher this morning as shares in the US rose on hopes of more stimulus measures. Markets were also given a boost by Covid vaccine news as pharmaceutical companies submit their paperwork for regulatory approvals. Zelira Therapeutics Ltd (ASX:ZLD) in partnership with SprinJene®, has launched of its proprietary CBD toothpaste in the US.

Read more...